Dr Bhabesh Nath Assistant Professor B N College, Dhubri Created on 12th May, 2022
What is RNA Interference?
RNAi is a natural, evolutionarily conserved cellular mechanism that uses small RNA molecules to selectively silence the expression of specific genes — controlling which proteins a cell produces.
Discovered by
Fire & Mello, 1998
Nobel Prize
Physiology / Medicine 2006
Key molecule
Small RNA (20–25 nt)
Primary target
mRNA transcripts
Three types of small RNA
siRNA — Small Interfering RNA
Double-stranded, 20–25 nt. Introduced externally into cells. Leads to degradation of specific mRNA, preventing translation of targeted genes into proteins. Used widely in gene-knockdown research and therapeutics.
miRNA — MicroRNA
Endogenous (~20–25 nt), produced naturally inside cells. Fine-tunes gene expression by inhibiting mRNA translation or promoting degradation. Partial complementarity means it can regulate multiple target genes.
piRNA — Piwi-interacting RNA
Distinct class, mainly active in the germline. Protects genomic stability against transposable elements that could otherwise insert randomly and disrupt genetic information across generations.
Mechanism of RNAi — step by step
1
Generation of small RNA
Long double-stranded RNA is processed by the enzyme Dicer (an RNase III-type enzyme) into short siRNA duplexes of 20–25 nucleotides complementary to the target mRNA sequence.
2
RISC assembly
The siRNA duplex is unwound and one strand (the guide strand) is loaded into the RNA-Induced Silencing Complex (RISC). Argonaute proteins are the key catalytic components of RISC.
3
Target mRNA recognition
The activated RISC complex scans cytoplasmic mRNAs. The guide strand directs RISC to complementary target mRNA through Watson-Crick base pairing.
4
Gene silencing
With perfect complementarity (siRNA) — Argonaute cleaves and degrades the mRNA. With partial complementarity (miRNA) — translational repression occurs. Either way, protein production from that gene is reduced or eliminated.
Biological roles of RNAi
Development
Controls timing and extent of gene expression during cell differentiation, body patterning, and tissue regeneration across animals and plants.
Immune response
Regulates host defence genes; viruses are particularly susceptible to RNAi-mediated silencing as a form of innate antiviral immunity.
Cancer biology
Aberrant miRNA expression alters the balance of oncogenes and tumour suppressor genes, contributing to tumorigenesis and cancer progression.
Neurodegeneration
RNAi therapies are being investigated to silence disease-associated genes in Alzheimer's and Huntington's disease, potentially slowing progression.
Applications in science & medicine
Functional genomics
RNAi is used as a research tool to systematically knock down specific genes and study their function, enabling genome-wide phenotypic screens.
Drug development
Novel RNAi-based therapeutics (e.g., FDA-approved siRNA drugs like Patisiran) are being developed for genetic disorders, viral infections, and cancer.
Agriculture
RNAi technology is employed in genetically modified crops to produce dsRNA targeting essential genes in insect pests, reducing reliance on chemical pesticides.
Gene therapy
RNAi has potential for treating dominantly inherited genetic diseases by specifically silencing the mutant allele while preserving the wild-type copy.
Challenges & future directions
Despite its immense potential, several challenges remain: ensuring specificity, avoiding off-target effects, efficient delivery of RNAi therapeutics into target tissues in vivo, immune activation concerns, and long-term stability. Researchers are developing nanoparticle-based (LNP) and viral vector delivery systems to address these limitations.
Off-target effectsDelivery challengesNanoparticle (LNP) deliveryTherapeutic specificityImmune activationIn vivo stability
RNAi pathway — concept map
An illustrated overview of how double-stranded RNA triggers gene silencing through the RISC complex. Click any node to explore that concept.
RNAi vs. normal gene expression
Feature
Normal gene expression
Under RNAi
mRNA fate
Translated into protein
Degraded or blocked
Protein output
Normal levels
Reduced / absent
Trigger
Transcription factors
dsRNA / small RNA
Key complex
Ribosome
RISC (Argonaute)
Specificity
Promoter-controlled
Sequence-specific
Reversibility
Regulated by TFs
Transient (siRNA) or stable
siRNA vs. miRNA — comparison
Feature
siRNA
miRNA
Origin
Exogenous / engineered
Endogenous (genomically encoded)
Complementarity
Perfect (100%)
Partial (seed region)
Silencing mode
mRNA cleavage & degradation
Translational repression
Target specificity
Single gene
Multiple genes
Therapeutic use
High (approved drugs)
Under investigation
Self-assessment quiz
Test your understanding of RNA Interference. 8 questions covering key concepts, mechanisms, and applications. Read carefully before selecting your answer.
Critical thinking challenges
Think through these open-ended questions independently, then reveal a hint to check your reasoning.
1. Why might a researcher choose siRNA over miRNA for a therapeutic application targeting a single disease gene?
Think about the difference in complementarity: siRNA requires perfect base pairing (highly specific to one gene), while miRNA allows partial matches (affecting multiple targets). For a therapeutic, specificity minimises off-target effects — making siRNA the preferred choice when you want to silence exactly one gene without disturbing others.
2. How might cancer cells evolve to escape RNAi-based therapies over time?
Consider: (a) mutations in the target mRNA sequence that break complementarity with the siRNA; (b) downregulation of RISC components (Dicer, Argonaute); (c) upregulation of mRNA export from the nucleus to evade RISC; (d) activation of compensatory signalling pathways. Tumour heterogeneity means any resistant subclone will be selected under therapy pressure.
3. piRNAs protect the germline from transposable elements. Why is this particularly important for evolution and heritability?
Transposable elements (TEs) can insert randomly into the genome — potentially disrupting coding genes, promoters, or regulatory regions. In somatic cells this may cause disease; in the germline it is heritable. If TE mobilisation in the germline were unchecked, it would dramatically increase the mutation rate across generations, threatening species fitness. piRNA-mediated silencing of TEs is thus an ancient genome-defence system conserved across animals.
4. The first RNAi-based drug (Patisiran) was approved in 2018 for a liver disease. Why is the liver a favourable organ for siRNA drug delivery compared to the brain?
The liver has high fenestration (open pores) in its capillaries and naturally takes up nanoparticles via LDL-receptor pathways, making lipid nanoparticles (LNPs) highly efficient at targeting hepatocytes. The brain, in contrast, is protected by the blood-brain barrier (BBB), which restricts most large molecules. Crossing the BBB requires special strategies like modified nanoparticles, direct injection, or nanoparticle surface engineering.
Web resources for further learning
Curated, peer-reviewed, and authoritative resources to deepen your understanding of RNAi.
Dr. Bhabesh Nath is an Assistant Professor in the Department of Zoology at B. N. College Autonomous with more than 16 years of teaching experience at the undergraduate and graduate levels. He has been actively involved in teaching, academic mentoring, dissertation guidance, and the development of innovative educational resources in Zoology and Life Sciences.
Dr. Nath serves as the SWAYAM Co-ordinator of B. N. College Autonomous and is also the Assistant Nodal Officer for Internship activities of the institution, contributing significantly to student skill development, online learning initiatives, and academic-industry engagement.
As the founder and content developer of zoologys.co.in, he is dedicated to making Zoology education accessible, interactive, and exam-oriented for students and educators. His academic interests include Cell Biology, Wildlife Biology, Ecology, Evolution, Genetics, Bioinformatics, and Zoological Practical Education.
Through zoologys.co.in, Dr. Nath regularly publishes study materials, laboratory manuals, MCQs, practical guides, question papers, e-content, and educational resources aligned with university curricula and UGC guidelines. His work emphasizes student-friendly explanations, visual learning, and ICT-enabled teaching-learning methods in higher education.
He is also actively involved in creating digital learning resources, online practical content, and academic support materials for B.Sc. and postgraduate students, teachers, and competitive examination aspirants across India.
Dr. Chandralekha Deka is an Assistant Professor in the Department of Zoology at Pandit Deendayal Upadhyaya Adarsha Mahavidyalaya (PDUAM). She is actively engaged in undergraduate teaching, academic mentoring, and the promotion of quality education in Zoology and Life Sciences.
Dr. Deka has been contributing to higher education through classroom teaching, practical training, student guidance, and academic activities aimed at strengthening scientific understanding among students. Her areas of academic interest include Cell Biology, Genetics, Ecology, Evolution, Environmental Biology, and Zoological Practical Education.
As an educator, she is dedicated to creating a student-friendly learning environment and encouraging scientific curiosity, critical thinking, and research-oriented learning among undergraduate students. She is also involved in academic resource development, practical-based teaching methodologies, and ICT-enabled learning approaches in higher education.
Through her teaching and academic contributions, Dr. Deka continues to support the advancement of Zoology education and student development in Assam and beyond.
Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis. Read More
0 Comments